3 most recent filings and news items mentioning SENSEI. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/SENSEI/news?limit=20"
Pull SENSEI filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/daySensei Biotherapeutics, Inc. has amended its Certificate of Incorporation to change its corporate name to Faeth Therapeutics, Inc., effective upon Delaware filing. The name change represents a rebranding of the biopharmaceutical company's corporate identity.
View filing at SEC.gov →Sensei Biotherapeutics increased authorized Common Stock from an undisclosed prior amount to 300 million shares and authorized Preferred Stock at 10 million shares, totaling 310 million authorized shares. The amendment provides capital structure flexibility for potential financin
View filing at SEC.gov →Sensei Biotherapeutics completed the acquisition of Faeth Therapeutics on February 17, 2026, issuing 10.5M Series B Preferred shares to Faeth shareholders and simultaneously raising $200M from investors. The transaction significantly expands the company's pipeline and provides su
View filing at SEC.gov →